Skip to main content
FOI release

FOI – 2023-000370 - Coagulation factors (HTML)

Published on 16 April 2024

Date received – 04 October 2023 | Date responded – 01 November 2023

Request

I would like to submit an FOI request for the following coagulation factors product:

  1. How many patients did you treat with Bypassing agents (BPA)/Hemlibra inhibitor in Q3’23 (July, August, September 2023)?

a. With BPA/Hemlibra Inhibitor?

  1. Please fill in the BPA/Hemlibra products utilized in July, August, and September 2023.

  2. How many minor and major surgeries did your BPA patients have in July, August, and September 2023?

  3. How many minor and major surgeries did your BPA/Hemlibra inhibitor patients have in July, August, and September 2023?

  4. How many breakthrough bleeds did your Hemlibra Inhibitor patients have, and what brand were they treated with?

  5. Were there any changes in the total number of acute bleeds treated with factor in Q3’23 as compared to Q2’23?

  6. Was there any change in the number of elective surgeries using factor in Q3’23 as compared to Q2’23?

  7. Have any BPA patients switched products between July 1st through September 30th 2023? What were the reasons for the switches?

  8. What is the total number of patients treated with NovoSeven at your NHS Scotland?

Response

I can advise you that we have now completed the search of our records and can provide you with the following information:

What we can provide you with is Appendix 1 - Units delivered to Homecare & Pharmacy, which shows the medicines (Hemblibra/Emicizumab and Novoseven) that have been delivered to Homecare patients and pharmacies. The data is for period 2022-23. We do not hold any data prior to this period as it is obtained on an ad hoc basis.

Attached is Appendix 2 – Framework NP30119 Homecare deliveries which details data from our NP30119 Homecare Clotting Factors framework agreement on units issued to homecare patients (not necessarily utilised) broken down by month. No units have been identified in the dataset for Novoseven for the periods requested.

If you wish to contact the local HBs this can be done using the following email addresses:

I trust you will find the information of assistance and if you require any further information, please do not hesitate to contact us.

If you are unhappy with any aspect of how we have dealt with your request, you can make representations to us asking us to review the handling of your request.

If you require any further information, please contact Head of Information and Cyber Security, Digital and Security within 40 working days of the date of this correspondence.

Contact

Address

NHS National Services Scotland
Headquarters
Gyle Square
1 South Gyle Crescent
Edinburgh
EH12 9EB

If after a review you are still unhappy, you also have the right to apply to the Scottish Information Commissioner, who can be contacted at Kinburn Castle, St Andrews, Fife, KY16 9DS, or via their application form.

National Services Scotland (NSS) is committed to publishing all information released in response to Freedom of Information requests. You can view all FOI responses within our FOI Publications repository.